Medical Countermeasures W.H.O. Partner Program Allocates 238,000 Doses of Mpox Vaccine to Four CountriesGlobal Biodefense StaffMarch 19, 2025
Medical Countermeasures Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical CountermeasuresGlobal Biodefense StaffMarch 18, 2025
Medical Countermeasures Tecovirimat Shown to Lack Efficacy as Treatment for Clade II MpoxGlobal Biodefense StaffMarch 12, 2025
Bolstering Pandemic Preparedness: HHS Funds Accelerated Development of H5N1 Vaccine Medical Countermeasures January 17, 2025 …
FDA Removes Clinical Hold on Novavax’s Combo COVID-Flu Vaccine Medical Countermeasures November 11, 2024 …
Humanetics Presents BIO 300 Radiation Countermeasure Data at DoD Scientific Meeting Medical Countermeasures October 3, 2024 …
GigaGen Wins BARDA Contract to Develop Biothreat Countermeasures Medical Countermeasures October 3, 2024 …
Acurx Announces Anthrax Susceptibility to ACX-375 Analogues Medical Countermeasures September 26, 2024 …
New Partnerships Boost Decentralized Clinical Trial Capacity for Public Health Emergencies Contracts + Grants August 27, 2024 …
Disappointing Results for Tecovirimat Mpox Trial in the DRC Medical Countermeasures August 15, 2024 …
Lassa Fever Vaccine Study Supports Advancement to Phase I Trial Medical Countermeasures August 14, 2024 …
Thylacine Biotherapeutics Earns Top Honor in Medical Threat Reduction Challenge Medical Countermeasures July 9, 2024 …
Maxwell Biosciences Enters CRADA with USAMRIID to Test Potential Therapeutics Industry News May 8, 2024 …
RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035 Medical Countermeasures May 6, 2024 …
Antiviral for Sudan Ebolavirus; Ebola Pathogenicity in Pigs; Repurposing SARS-CoV-2 Drugs for Marburg Pathogens April 3, 2024 …
Study on Ebola Vaccines and Boosting Regimen Contributes to Future Outbreak Preparedness Medical Countermeasures April 3, 2024 …
ReAlta Development of RLS-0071 as Acute Radiation Syndrome Medical Countermeasure Medical Countermeasures March 28, 2024 …
Rafa Laboratories Partners with BARDA to Advance New Design for Pediatric Atropine Autoinjectors CBRNE March 20, 2024 …
Primmune Therapeutics Awarded DTRA Funding for Lassa Fever Antiviral Medical Countermeasures March 20, 2024 …
